AI assistant
InspireMD, Inc. — Director's Dealing 2016
Sep 8, 2016
34187_dirs_2016-09-08_d93fc6d2-686d-4ff3-b6a2-6a9e1ba99d26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-09-06
Reporting Person: Kester Thomas J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-06 | Options to purchase common stock (right to buy) | $0.13 | A | 250000 | Acquired | 2026-09-06 | Common Stock (250000) | Direct |
Footnotes
F1: The options vest and become exercisable in three equal annual installments, with 1/3 of the options (rounded down for fractional shares) becoming exercisable on September 6, 2017, an additional 1/3 of the options (rounded down for fractional shares) becoming exercisable on September 6, 2018, and the remaining options becoming exercisable on September 6, 2019, provided that the options vest in full and become exercisable immediately on such date that the Reporting Person is not re-elected as a director at the Issuer's 2017 annual meeting of stockholders or such date that the Reporting Person is not re-nominated as a director for the Issuer's 2017 annual meeting of stockholders.